Acquiring funding for these types of studies is a challenge—the stigmatization of psilocybin has prompted governmental funding bodies to stay away from projects involving the compound. Nonetheless, Nichols thinks that, as trials demonstrating the prospective benefits of psilocybin keep popping out, there may be a bigger push and incentive for https://cristianaalv489488.atualblog.com/36630598/indicators-on-benefits-of-copyright-mushrooms-you-should-know